• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalenecarboxylic acids and derivatives Naphthalenecarboxylic acids

Recent Advances in the Study of 6-Methoxy-5-(trifluoromethyl)-1-naphthoic acid (CAS: 84532-72-9)

6-Methoxy-5-(trifluoromethyl)-1-naphthoic acid (CAS: 84532-72-9) is a naphthoic acid derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have explored its role as a key intermediate in the synthesis of bioactive compounds, particularly in the development of anti-inflammatory and anticancer agents. This research brief aims to summarize the latest findings related to this compound, highlighting its synthesis, biological activities, and potential applications in drug discovery.

The compound's chemical structure, characterized by a methoxy group at the 6-position and a trifluoromethyl group at the 5-position of the naphthalene ring, imparts distinct electronic and steric properties that influence its reactivity and interaction with biological targets. Recent synthetic methodologies have focused on optimizing the yield and purity of 6-Methoxy-5-(trifluoromethyl)-1-naphthoic acid, with advancements in catalytic processes and green chemistry approaches. These improvements have facilitated its broader use in medicinal chemistry and drug development.

In terms of biological activity, recent in vitro and in vivo studies have demonstrated that 6-Methoxy-5-(trifluoromethyl)-1-naphthoic acid exhibits promising anti-inflammatory effects by modulating key signaling pathways such as NF-κB and MAPK. Additionally, its potential as an anticancer agent has been explored, with evidence suggesting inhibitory effects on tumor cell proliferation and metastasis. These findings underscore the compound's versatility and its potential as a scaffold for the design of novel therapeutics.

Further research has also investigated the pharmacokinetic and toxicological profiles of 6-Methoxy-5-(trifluoromethyl)-1-naphthoic acid, providing insights into its bioavailability, metabolism, and safety. These studies are critical for advancing the compound into preclinical and clinical development stages. Collaborative efforts between academic institutions and pharmaceutical companies are expected to accelerate the translation of these discoveries into viable drug candidates.

In conclusion, 6-Methoxy-5-(trifluoromethyl)-1-naphthoic acid (CAS: 84532-72-9) represents a promising chemical entity with diverse applications in drug discovery and development. Ongoing research efforts are likely to uncover additional therapeutic potentials and optimize its synthetic and pharmacological properties. This brief serves as a timely update for researchers and industry professionals engaged in the exploration of naphthoic acid derivatives and their biomedical applications.

• 4864-01-1(2-Methoxy-5-(trifluoromethyl)benzoic acid)
• 213598-09-5(4-Methoxy-3-(trifluoromethyl)benzoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)